Firefly Neuroscience, Inc. AIFF

Company Overview

Firefly Neuroscience, Inc. (NASDAQ: AIFF) is a neuroscience technology company focused on artificial intelligence-enabled brain health assessment and neurodiagnostic analytics. The company develops software and data-driven platforms intended to support clinicians, researchers, and pharmaceutical organizations in the evaluation of brain activity, cognitive disorders, and neurological conditions. Firefly operates within the broader healthcare technology, neuroinformatics, and digital health industries, with an emphasis on electroencephalography (EEG) data analysis and AI-assisted neurological interpretation.

The company’s core business model centers on proprietary neurological data assets, software analytics, and clinical support tools designed to improve diagnostic insight and patient stratification. Public filings indicate that Firefly has positioned itself around the integration of machine learning with brainwave analysis to support mental health, neurology, and clinical research applications. The company evolved through corporate restructuring and public-market transactions that expanded its access to capital markets and technology commercialization opportunities. Certain historical corporate details and timeline elements vary across public disclosures; data is partially inconclusive based on available public sources.